Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Technology
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Visual Stories
  • Reviews
  • Phone Reviews
  • Fitness Bands Reviews
  • Speakers Reviews
  • Find Cricket Statistics
Hindi
More
In the news
Monsoon
Raksha Bandhan
NV Ramana
Coronavirus India
Coronavirus Cases In India
75 years of Independence
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Technology
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Visual Stories
Reviews
Phone Reviews
Fitness Bands Reviews
Speakers Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / India News / India gears up to develop key COVID-19 drug: Details here
India

India gears up to develop key COVID-19 drug: Details here

India gears up to develop key COVID-19 drug: Details here
Written by Shubham Sharma
May 05, 2020, 01:13 pm 2 min read
India gears up to develop key COVID-19 drug: Details here

The US recently approved Remdesivir, a key antiviral drug from Gilead Sciences, for emergency use on COVID-19 patients. Now, India appears to be working on its development, with the Hyderabad-based Indian Institute of Chemical Technology synthesizing key starting materials (KSMs) for Remdesivir - the first step of developing an active pharmaceutical ingredient for a drug. Here's all you need to know about it.

Development
Three KSMs prepared by IICT

In a recent conversation with Hindustan Times, Dr. Srivari Chandrasekhar, the Director of IICT, said that Remdesivir has three KSMs - Pyrrole, Furan, and a Phosphate intermediate - and synthesizing them is a key step towards drug development. "These key starting materials for Remdesivir are available in India and chemical companies can manufacture these," he said. "Other reagents can be sourced from different countries."

Demonstrations
Technology demonstrations for manufacturing

Along with material synthesis, IICT has also started technology demonstrations for leading pharmaceutical companies, like Cipla, with the goal to enable them to begin manufacturing in India, if the need arises. However, it is worth noting that Gilead Sciences, the company that has developed Remdesivir, holds a patent that allows the drug to be manufactured only for research, not commercialization.

Efficacy
Remdesivir has proven effective in clinical trials

The move from IICT, which has also been confirmed by Health Minister Dr. Harsh Vardhan, comes in light of Remdesivir's promising performance in initial clinical trials on COVID-19 patients. Specifically, the drug was administered on coronavirus patients, under the guidance of the US National Institute of Allergy and Infectious Diseases, and was able to help them recover four days sooner than other placebo-involving treatments.

Remarks
However, Health Ministry said US study is inconclusive

However, following US's nod to Remdesivir, the Ministry of Health and Family Welfare said that the study conducted is inconclusive and it is waiting for 'larger evidence' to support its use. India has received 1,000 doses of the drug for WHO's Solidarity Trials, and now, with the support from IICT, that capacity is likely to be increased for more comprehensive clinical testing.

Information
"Work started back in January"

"We started working on KSM for Remdesivir in January-end when trials had begun in China," Dr. Chandrasekhar told HT while noting the institute is also working with the private pharma industry to carry out clinical trials of Favipiravir, another promising COVID-19 drug.

Share this timeline
Facebook
Whatsapp
Twitter
Linkedin
Shubham Sharma
Shubham Sharma
Twitter
Editor with over five years of experience in covering all things science, consumer tech, space tech, AI, infosec, and business. A commerce graduate from University of Lucknow. I have been handling Tech beat at NewsBytes since 2018.
Latest
Hindustan Times
Harsh Vardhan
HT
United States of America
Ministry of Health and Family Welfare
Related
Latest
Here's how to redeem Free Fire MAX's August 11 codes
Here's how to redeem Free Fire MAX's August 11 codes Technology
'Kaithi 2' to roll out next year, confirms Karthi
'Kaithi 2' to roll out next year, confirms Karthi Entertainment
5 food mistakes to avoid before exercising
5 food mistakes to avoid before exercising Lifestyle
Happy birthday, Suniel Shetty! Looking at his best comic roles
Happy birthday, Suniel Shetty! Looking at his best comic roles Entertainment
5 noted films and shows leaving Netflix India in August
5 noted films and shows leaving Netflix India in August Entertainment
Hindustan Times
No foreign leader as R-Day chief guest this year: Report
No foreign leader as R-Day chief guest this year: Report India
Ahead of nationwide exercise, COVID-19 vaccine dry run in Haryana
Ahead of nationwide exercise, COVID-19 vaccine dry run in Haryana India
Fashion designer Swapnil Shinde comes out as a transwoman
Fashion designer Swapnil Shinde comes out as a transwoman Entertainment
Toxic gas leak at SAIL's Rourkela plant kills four workers
Toxic gas leak at SAIL's Rourkela plant kills four workers India
17 dead as roof of cremation ground collapses in Muradnagar
17 dead as roof of cremation ground collapses in Muradnagar India
More News
Harsh Vardhan
Meet Mansukh Mandaviya, who replaced Harsh Vardhan as Health Minister
Meet Mansukh Mandaviya, who replaced Harsh Vardhan as Health Minister Politics
Harsh Vardhan, Ravi Shankar, Prakash Javadekar quit before Cabinet reshuffle
Harsh Vardhan, Ravi Shankar, Prakash Javadekar quit before Cabinet reshuffle Politics
July has come, vaccines haven't, says Rahul; BJP hits back
July has come, vaccines haven't, says Rahul; BJP hits back Politics
India strongly opposes 'COVID-19 vaccine passport' idea at G7 meet
India strongly opposes 'COVID-19 vaccine passport' idea at G7 meet India
Gehlot slams Dr. Vardhan on issue of availability of vaccines
Gehlot slams Dr. Vardhan on issue of availability of vaccines Politics
More News
HT
Galwan hero could be posthumously awarded Mahavir Chakra on R-Day
Galwan hero could be posthumously awarded Mahavir Chakra on R-Day India
Indo-China clash reported in Sikkim, both sides suffer injuries
Indo-China clash reported in Sikkim, both sides suffer injuries India
How will coronavirus vaccine reach Indians? Centre outlines plan
How will coronavirus vaccine reach Indians? Centre outlines plan India
20 more people contract new coronavirus strain, tally reaches 58
20 more people contract new coronavirus strain, tally reaches 58 India
Delhi records 1.1°C, coldest New Year's Day in 15 years
Delhi records 1.1°C, coldest New Year's Day in 15 years India
More News
United States of America
IIT Bombay records highest job offers, packages this academic year
IIT Bombay records highest job offers, packages this academic year Career
Taiwan accuses China of using drills to 'prepare for invasion'
Taiwan accuses China of using drills to 'prepare for invasion' World
US: Explosion at Google's data center critically injures 3 people
US: Explosion at Google's data center critically injures 3 people World
Trump claims FBI 'raided' his Florida home, broke into safe
Trump claims FBI 'raided' his Florida home, broke into safe World
New York: Tortured for having daughters, UP woman kills herself
New York: Tortured for having daughters, UP woman kills herself World
More News
Ministry of Health and Family Welfare
India to battle monkeypox with targeted 'ring vaccination' strategy
India to battle monkeypox with targeted 'ring vaccination' strategy India
Monkeypox outbreak: 9 cases reported so far, 4 in Delhi
Monkeypox outbreak: 9 cases reported so far, 4 in Delhi Delhi
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech
Clinical trials for nasal COVID-19 vaccine complete: Bharat Biotech India
NEET-PG 2022 exam not postponed, fake notice being circulated: NBE
NEET-PG 2022 exam not postponed, fake notice being circulated: NBE India
All existing COVID-19 restrictions to be lifted from March 31
All existing COVID-19 restrictions to be lifted from March 31 India
More News
Related
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October
Biological E-manufactured J&J's single-dose COVID-19 vaccine in India by October India
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA
US: Pfizer-BioNTech COVID-19 vaccine officially granted full approval by FDA World
Next News Article
Next News Article

Love India news?

Subscribe to stay updated.

India Thumbnail
India News Business News World News Politics News Sports News Technology News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Mukesh Ambani Indian Premier League (IPL) Karnataka Samsung Xiaomi West Bengal
Bihar Virat Kohli Rohit Sharma Haryana Narendra Modi Arvind Kejriwal Tamil Nadu Gujarat Yogi Adityanath YouTube
Instagram Hollywood News Uttar Pradesh Kerala Netflix Bollywood News Mamata Banerjee Maruti Suzuki Rahul Gandhi Elon Musk
Shah Rukh Khan Chelsea FC OPPO Akhilesh Yadav Indian Cricket Team Apple Manchester United Salman Khan Cryptocurrency OnePlus
Amitabh Bachchan ICC Women's World Cup Vivo India vs Sri Lanka
About Us Privacy Policy Terms & Conditions Contact Us Ethical Conduct Grievance Redressal News News Archive Topics Archive IPL 2022 Schedule IPL 2022 Points Table Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2022